Hint mode is switched on Switch off
Cbonds API
Integrate prices, fundamentals and corporate actions into your workflow

Get Global Stock Data via API

  • Prices & history
  • Fundamentals
  • Dividends & corporate actions

ARS Pharmaceuticals, ordinary share
SPRY, US82835W1080

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
ARS Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in
API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

Included in the Free Plan
  • 100,000+ Stocks
  • 17,000+ ETFs
  • 150,000+ Mutual Funds

Start exploring global markets in less than 1 minute

  • Global Macro & Commodity Data
  • Research Hub & Basic Market News
  • AI Bond Screener
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
ARS is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis.
  • Issuer
  • Full borrower / issuer name
    ARS Pharmaceuticals Inc (formerly Silverback Therapeutics Inc)
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SPRY
  • Placement
    04.12.2020
  • Lock up period
    180
  • Number of papers
    11,500,000
  • Volume of raised funds
    241.5 mln USD
  • Raised funds in USD
    -
  • Placement share
    34.78%
  • Final placement price
    21 USD
  • Price change since placement date
    -100%
  • By capitalization
    694.4 mln USD

Indicators

Holders

Related Stock indices

  • NASDAQ Composite
    26,081.72
    Value
    10/09/2026
    Date

Industry Leaders

Registration is required to get access.